Pharma Journalist -

Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have entered into an exclusive licensing and collaboration agreement to develop and commercialize INBRIJA® (levodopa…
Read More...

Insilico Medicine and Human Life Foundation Models, Inc. (HLFM) have entered into a multi-million-dollar collaboration to develop what the companies describe as the biotechnology…
Read More...

Autobahn Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to elunetirom, the company’s lead investigational therapy for the…
Read More...

Eli Lilly and Company reported positive interim results from the Phase 1b Heart-2 clinical study of VERVE-102, an investigational gene-editing therapy designed to lower low-density…
Read More...

Pierre Fabre Laboratories announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of…
Read More...

The energy coming out of this year’s ATS meeting was unmistakable: respiratory medicine is entering a new era of scientific ambition, cross‑industry collaboration, and patient‑centred…
Read More...

Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living…
Read More...

AbbVie announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of MAVIRET®…
Read More...

AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic…
Read More...

Regeneron Pharmaceuticals said the European Medicines Agency (EMA) has accepted for review under its Accelerated Assessment pathway the Marketing Authorization Application (MAA) for…
Read More...